Axonics® is dedicated to improving the quality of life of people suffering from bladder and bowel dysfunction, conditions that impact the lives of tens of millions of adults globally. The Company’s products include the Axonics Sacral Neuromodulation System designed to treat overactive bladder and fecal incontinence and the Bulkamid® hydrogel designed to treat women with stress urinary incontinence. For more information, visit www.axonics.com and www.bulkamid.com.
Axonics, Inc. (Nasdaq: AXNX) is headquartered in Irvine, California.
Location: United States, California, Irvine
Employees: 201-500
Phone: +1 877-929-6642
Founded date: 2013
Investors 1
| Date | Name | Website |
| - | Longitude ... | longitudec... |
Mentions in press and media 11
| Date | Title | Description | Source |
| 09.01.2024 | Why Carta’s public battle might be a private markets nightma... | To say the Carta news that broke over the weekend has caused a furor in the startup world is an unde... | fortune.co... |
| 08.01.2024 | Boston Scientific Continues Buying Spree with $3.7B Axonics ... | Medical device giant Boston Scientific announced a $3.7 billion deal on Monday to augment its urolog... | medcitynew... |
| 17.11.2021 | Deloitte Fast 500: Medical device company takes the top spot... | For the 26th straight year, software companies continued to dominate the Deloitte Technology Fast 50... | techrepubl... |
| 05.11.2021 | Corporate Presentation | Investor Presentation November 2021 | Nasdaq: AXNX Disclaimer This presentation contains forward-loo... | marketscre... |
| 06.05.2021 | Axonics® Reports First Quarter 2021 Financial Results | Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commerciali... | neomed.net... |
| 25.02.2021 | Axonics® Reports Fourth Quarter and Fiscal Year 2020 Results... | Axonics Modulation Technologies, Inc. (Nasdaq: AXNX), a medical technology company that has develope... | neomed.net... |
| 23.09.2020 | Healthcare VC Firm Longitude Capital Closes $585M Fund | What You Should Know: – Healthcare venture capital firm Longitude Capital announces the close of its... | hitconsult... |
| 23.09.2020 | Longitude Capital Raises $585 Million Fund to Invest in Tran... | - Longitude Venture Partners IV will build on the Firm’s commitment to improve clinical outcomes, en... | marketscre... |
| 06.08.2020 | Axonics® Reports Second Quarter 2020 Results | Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company that has develope... | neomed.net... |
| 04.03.2020 | Axonics® Announces Fourth Quarter and Fiscal 2019 Financial ... | Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company that has develope... | neomed.net... |
Show more